My ePortfolio Register   

ESMO 2017 /
Chemotherapy remains best treatment for locally advanced cervical cancer

8th - 12th Sep 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 11.09.17
Views: 479
Rating:

Prof Sudeep Gupta - Tata Memorial Hospital, Mumbai, India

Prof Gupta talks with ecancer at the ESMO 2017 Congress about a randomised controlled trial looking at neoadjuvant chemotherapy followed by surgery versus concurrent cisplatin and radiation therapy in patients with stage IB2 to IIB squamous carcinoma of cervix.

He goes on to discuss the results of the trial and explains that chemotherapy remains the best choice treatment for locally advanced cervical cancer.

For more information watch the press conference here or read the news story

ecancer's filming has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence